EHRs, Worth the Hassle? : ‘Meaningful use’ criteria can pose high hurdle for derms Allergan Settles : Drugmaker to pay $600 million to resolve off-label marketing charges Special Report : Hair & Nails
POLL: Are You Attending Maui Derm NP+PA Fall 2023?
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Abeona Submits Biologics License Application to FDA for EB-101
Botulinum Toxin Lacks Significant Effect in Seborrheic Dermatitis, Study Says